Biodesix, Inc. (BDSX)
USD 0.52
(-1.52%)
USD 0.52
(-1.52%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.4 Million USD | 0.0% |
| 2022 | 1.4 Million USD | -51.72% |
| 2021 | 2.9 Million USD | -9.38% |
| 2020 | 3.2 Million USD | 300.0% |
| 2019 | 800 Thousand USD | 14.29% |
| 2018 | 700 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 1.2 Million USD | -100.0% |
| 2024 Q2 | 1.2 Million USD | -14.29% |
| 2024 Q1 | 1.4 Million USD | 0.0% |
| 2023 Q3 | 1.3 Million USD | -7.14% |
| 2023 FY | 1.4 Million USD | 0.0% |
| 2023 Q4 | 1.4 Million USD | 7.69% |
| 2023 Q2 | 1.4 Million USD | 7.69% |
| 2023 Q1 | 1.3 Million USD | -7.14% |
| 2022 Q2 | 1.9 Million USD | -26.92% |
| 2022 Q1 | 2.6 Million USD | -10.34% |
| 2022 FY | 1.4 Million USD | -51.72% |
| 2022 Q4 | 1.4 Million USD | 0.0% |
| 2022 Q3 | 1.4 Million USD | -26.32% |
| 2021 Q1 | 3.4 Million USD | 6.25% |
| 2021 FY | 2.9 Million USD | -9.38% |
| 2021 Q4 | 2.9 Million USD | 11.54% |
| 2021 Q3 | 2.6 Million USD | -16.13% |
| 2021 Q2 | 3.1 Million USD | -8.82% |
| 2020 Q2 | 1.8 Million USD | 0.0% |
| 2020 Q4 | 3.2 Million USD | 0.0% |
| 2020 Q3 | 3.2 Million USD | 77.78% |
| 2020 FY | 3.2 Million USD | 300.0% |
| 2020 Q1 | - USD | -100.0% |
| 2019 FY | 800 Thousand USD | 14.29% |
| 2019 Q4 | 800 Thousand USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2018 FY | 700 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | - USD | -Infinity% |
| Applied DNA Sciences, Inc. | 330.02 Thousand USD | -324.208% |
| Aspira Women's Health Inc. | 227 Thousand USD | -516.74% |
| BioNexus Gene Lab Corp. | 1.13 Million USD | -23.048% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -7474.118% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -7474.118% |
| Bionano Genomics, Inc. | 22.89 Million USD | 93.885% |
| CareDx, Inc | 19.47 Million USD | 92.81% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Castle Biosciences, Inc. | 7.94 Million USD | 82.372% |
| DarioHealth Corp. | 5.06 Million USD | 72.343% |
| Exact Sciences Corporation | 127.47 Million USD | 98.902% |
| Fulgent Genetics, Inc. | 5.82 Million USD | 75.974% |
| Guardant Health, Inc. | 61.94 Million USD | 97.74% |
| ICON Public Limited Company | 1.00 USD | -139999900.0% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | 99.632% |
| Illumina, Inc. | 587 Million USD | 99.761% |
| Intelligent Bio Solutions Inc. | 777.53 Thousand USD | -80.056% |
| iSpecimen Inc. | - USD | -Infinity% |
| Standard BioTools Inc. | 20.53 Million USD | 93.182% |
| MDxHealth SA | 2.77 Million USD | 49.622% |
| 23andMe Holding Co. | 12.46 Million USD | 88.769% |
| Medpace Holdings, Inc. | 1.00 USD | -139999900.0% |
| Myriad Genetics, Inc. | 20.1 Million USD | 93.035% |
| Mainz Biomed B.V. | 613.63 Thousand USD | -128.148% |
| ENDRA Life Sciences Inc. | 2.62 Million USD | 46.623% |
| NeoGenomics, Inc. | 24.15 Million USD | 94.204% |
| Neogen Corporation | 189.26 Million USD | 99.26% |
| Inotiv, Inc. | 56.1 Million USD | 97.505% |
| Natera, Inc. | 40.75 Million USD | 96.565% |
| OPKO Health, Inc. | 65.69 Million USD | 97.869% |
| Psychemedics Corporation | 1.00 USD | -139999900.0% |
| Prenetics Global Limited | 3.12 Million USD | 55.225% |
| Prenetics Global Limited | 3.12 Million USD | 55.225% |
| Precipio, Inc. | 384 Thousand USD | -264.583% |
| Personalis, Inc. | 5.66 Million USD | 75.269% |
| RadNet, Inc. | 1.00 USD | -139999900.0% |
| Sera Prognostics, Inc. | - USD | -Infinity% |
| Sotera Health Company | 51.98 Million USD | 97.307% |
| Neuronetics, Inc. | 8.09 Million USD | 82.701% |
| Star Equity Holdings, Inc. | 3.42 Million USD | 59.064% |
| Star Equity Holdings, Inc. | 3.42 Million USD | 59.064% |
| Trinity Biotech plc | 19.93 Million USD | 92.976% |
| Twist Bioscience Corporation | 32.06 Million USD | 95.634% |
| Exagen Inc. | 2.87 Million USD | 51.237% |